GSK3B and obesity due to melanocortin 4 receptor deficiency: Additionally, previous studies have reported that obesity from a HFD decreases the activity of the hippocampal insulin signaling pathway, including the activity of IRS-1, PI3K, p-PDK1, p-AKT, and p-GSK-3β [28,29].